knowledge -WSS

knowledge

author：knowledge 2025-08-13 12:26:54 Page View：191

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The new shift in health care is toward less care
Next article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

focus

Guidelines to prevent youth baseball injuries need more muscle

Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem

A rare thyroid diagnosis led to unexpected, all

Photoillustration:CaseySheneryforSTATAnnieLarsson,40,isnostrangertochronicconditions.Shewasdiagnosed

The cancer drug shortage isn’t new — and neither are the solutions

PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

Humana sues Biden admin over Medicare Advantage audit rule

HumanasuedthefederalgovernmentFridayoverarulethatclawsbackoverpaymentsfromitandotherMedicareAdvantag

knowledge

leisure time

focus

Humana sues Biden admin over Medicare Advantage audit rule